RecallDepth
Class III Terminated

Carboplatin Injection, 10 mg/mL, a) 5 mL multi-dose vials (NDC 61703-339-18) (NDC 61703-360-18, NOVAPLUS), b) 45 mL multi-dose vials (NDC 61703-339-50) (NDC 61703-360-50 NOVAPLUS), Rx only, Hospira, Inc., Lake Forest, IL 60045, Product of Australia

This recall has been terminated (originally issued August 22, 2012).

Company
Hospira Inc.
Recall Initiated
July 2, 2012
Posted
August 22, 2012
Recall Number
D-1648-2012
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
77,542 vials
Firm Location
Lake Forest, IL, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed PH specification: The lots of Carboplatin Injection were manufactured from Carboplatin API lots which trended out of specification low pH.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

5 mL vial - NDC 61703-339-18 (Hospira label), lot number Y031654AB, expiration APR2013; NDC 61703-360-18 (Novoplus label), lot number Y031654AA, expiration APR2013; 45 mL vial - NDC 61703-339-50 (Hospira label), lot numbers Y041711AA, expiration DEC 2012 and Y061711AB, expiration FEB 2013; NDC 61703-360-50 (Novoplus label), lot number Y061711AA, expiration FEB 2013

More recalls by Hospira Inc.

View all recalls by this company →

Other recent Class III Drug recalls